X-ray Characterization and Structure-Based Optimization of Striatal-Enriched Protein Tyrosine Phosphatase Inhibitors
作者:Michael R. Witten、Lisa Wissler、Melanie Snow、Stefan Geschwindner、Jon A. Read、Nicholas J. Brandon、Angus C. Nairn、Paul J. Lombroso、Helena Käck、Jonathan A. Ellman
DOI:10.1021/acs.jmedchem.7b01292
日期:2017.11.22
point to the promising potential of STEP as a target for drug discovery in Alzheimer’s treatment. We previously reported a substrate-based approach to the development of low molecular weight STEP inhibitors with Ki values as low as 7.8 μM. Herein, we disclose the first X-ray crystal structures of inhibitors bound to STEP and the surprising finding that they occupy noncoincident binding sites. Moreover
There is provided a substituted bis(trifluorovinyl)benzene compound that is excellent in heat stability and is industrially useful, and a method for producing the same. There are used a substituted bis(trifluorovinyl)benzene compound represented by general formula (1);
and a method for producing a substituted bis(trifluorovinyl)benzene compound, comprising the step of reacting in the presence of a catalyst (such as palladium) a bishalobenzene derivative represented by general formula (3)
and a compound obtained by reacting 1,1,1,2-tetrafluoroethane, a zinc halide, and an organolithium compound and represented by general formula (4),
to thereby obtain a substituted bis(trifluorovinyl)benzene compound represented by general formula (1).
IMIDAZOLE COMPOUND PRODUCTION METHOD, IMIDAZOLE COMPOUND, IMIDAZOLE-BASED COMPOUND, ORGANIC METAL COMPLEX, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, AND LIGHTING DEVICE
申请人:Idemitsu Kosan Co., Ltd.
公开号:EP2662365A1
公开(公告)日:2013-11-13
A manufacturing method of an imidazole compound represented by a formula (1) below includes reacting 1-arylimidazole with a halogen-atom substituted compound. For performing this reaction, in a reaction system, a mole number Nf(2) [mol] of the halogen-atom substituted compound and a total volume Vsol [liter] of an ether solvent having at most 5 carbon atoms satisfy a relationship of Vsol/Nf(2)≤3.
In the formula (1): R1 and R4 represent a substituent and the like; Z1 represents a group of atoms necessary for forming a hydrocarbon cyclic group and the like; R2 and R3 represent a bond, a hydrogen atom or an aromatic hydrocarbon group; Z2 represents a group of atoms necessary for forming a five-membered hydrocarbon ring and the like together with C-C; and m represents an integer of 1 to 5.
NOVEL COMPOUND HAVING ABILITY TO INHIBIT 11B-HSD1 ENZYME OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, METHOD FOR PRODUCING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT
申请人:BAMICHEM CO., LTD
公开号:EP2865664A1
公开(公告)日:2015-04-29
The present invention relates to a novel compound or a pharmaceutically acceptable salt thereof inhibiting 11β-HSD1 enzyme activity, a preparation method of the same, and a pharmaceutical composition comprising the same as an active ingredient. Since the compound of the present invention selectively inhibits the activity of 11β-HSD1 (11β-Hydroxysteroid dehydrogenase type 1), the compound of the invention can be effectively used as a therapeutic agent for the treatment of diseases caused by the over-activation of 11β-HSD1 such as non-insulin dependent type II diabetes, insulin resistance, obesity, lipid disorder, metabolic syndrome, and other diseases or condition mediated by the excessive activity of glucocorticoid.
本发明涉及一种抑制11β-HSD1酶活性的新型化合物或其药学上可接受的盐、其制备方法以及以其为活性成分的药物组合物。由于本发明化合物可选择性地抑制 11β-HSD1(11β-羟类固醇脱氢酶 1 型)的活性,因此本发明化合物可有效地用作治疗剂,用于治疗由 11β-HSD1 过度激活引起的疾病,如非胰岛素依赖型 II 型糖尿病、胰岛素抵抗、肥胖、血脂紊乱、代谢综合征和其他由糖皮质激素过度活性介导的疾病或病症。
Substituted bis(trifluorovinyl)benzene compound
申请人:TOSOH FINECHEM CORPORATION
公开号:US10654779B2
公开(公告)日:2020-05-19
There is provided a substituted bis(trifluorovinyl)benzene compound that is excellent in heat stability and is industrially useful, and a method for producing the same. There are used a substituted bis(trifluorovinyl)benzene compound represented by general formula (1);
and a method for producing a substituted bis(trifluorovinyl)benzene compound, comprising the step of reacting in the presence of a catalyst (such as palladium) a bishalobenzene derivative represented by general formula (3)
and a compound obtained by reacting 1,1,1,2-tetrafluoroethane, a zinc halide, and an organolithium compound and represented by general formula (4),
to thereby obtain a substituted bis(trifluorovinyl)benzene compound represented by general formula (1).